{"title": "Las principales barreras comerciales por superar para lograr un acceso global de la vacuna contra el COVID \u2013 19 | MINCIT", "author": "Euphoria-Net Com", "url": "https://acuerdosrevista.mincit.gov.co/articulos/las-principales-barreras-comerciales-por-superar-p", "hostname": "mincit.gov.co", "description": "A.Introducci\u00f3n El SARS \u2013 CoV \u2013 2 (en ingl\u00e9s \u201cSevere Acute Respiratory Syndrome\u201d coronavirus 2, 'coronavirus tipo 2 del s\u00edndrome respiratorio agudo grave'), el virus causante de la COVID \u2013 19, ha impactado significativamente todos los \u00e1mbitos de la vida moderna, causando un colapso econ\u00f3mico a escala global[1] y obligando a todos los Estados a tomar medidas excepcionales de control, como lo son los aislamientos obligatorios de la poblaci\u00f3n. [1] World Bank, COVID-19 to Plunge Global Economy into Worst Recession since World War II. Press Release, 8 de junio de 2020. Disponible en la web: https://www.worldbank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii (Consultado el 3 de septiembre de 2020)", "sitename": "Acuerdos revista", "date": "2020-12-23", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[[4]](#_ftnref4)\nWorld Trade Organization. The WTO and the Millennium Development Goals - Access to Medicines\n. Disponible en: https://www.wto.org/english/thewto_e/coher_e/mdg_e/medicine_e.htm. (Consultado el 24 de Julio de 2020)\n[[6]](#_ftnref6)\nBBC. Vacuna de AstraZeneca y Oxford contra la covid-19: interrumpen las pruebas por un caso de reacci\u00f3n adversa de un participante,\nBBC News. Disponible en la web:\n[https://www.bbc.com/mundo/noticias-54082322](https://www.bbc.com/mundo/noticias-54082322)\n(Consultado el 10 de Septiembre de 2020)\n[[11]](#_ftnref11)\nOrganizaci\u00f3n Mundial de la Salud, World Health Statistics 2020\n, Ginebra, 2020. Disponible en la web:\n[https://apps.who.int/iris/bitstream/handle/10665/332070/9789240005105-eng.pdf](https://apps.who.int/iris/bitstream/handle/10665/332070/9789240005105-eng.pdf)\n(Consultado el 28 de septiembre de 2020) \u201cEl virus del papiloma humano (VPH) es la infecci\u00f3n viral m\u00e1s com\u00fan del tracto reproductivo y puede causar c\u00e1ncer cervical. La vacuna dirigida a ni\u00f1as de 9 a 14 a\u00f1os se ofrece ahora en 90 pa\u00edses, pero a\u00fan no ha llegado a los pa\u00edses m\u00e1s pobres donde el riesgo de c\u00e1ncer de cuello uterino es mayor. La cobertura global para un curso completo de vacunas contra el VPH aument\u00f3 del 3% en 2010 al 12% en 2018\u201d \u2013 Traducci\u00f3n libre\n[[24]](#_ftnref24)\nFakultas Kedokteran Universitas Padjadjaran/RS Hasan Sadikin, Balitbangkes, Sinovac Life Sciences, a phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety and immunogenicity of sars-cov-2 inactivated vaccine in healthy adults aged 18-59 years in Indonesia\n, Indonesia Registry Web Portal, l7 de agosto de 2020. Disponible en la web:\n[https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX](https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX)\n(Consultado el 13 de septiembre de 2020).\n[[25]](#_ftnref25)\nChinese Clinical Trial Registry, A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)\n, 19 de julio de 2020. Disponible en la web:\n[http://www.chictr.org.cn/showprojen.aspx?proj=56651](http://www.chictr.org.cn/showprojen.aspx?proj=56651)\n. (Consultado el 13 de septiembre de 2020).\n[[35]](#_ftnref35)\nInternational Trade Center, Covid \u2013 19 temporary trade measures\n. Disponible en la web:\n[https://www.macmap.org/covid19](https://www.macmap.org/covid19)\n(Consultado el 13 de septiembre de 2020). Este fen\u00f3meno se vio con bienes para atender la emergencia sanitaria causada por la COVID 19, Con art\u00edculos como los tapabocas. Un total de 94 pa\u00edses impusieron medidas restrictivas al comercio de estos bienes.\n[[40]](#_ftnref40)\nErtola, Yantorno y Mignone ,OEA,. Microbiologia Industrial\n. OEA. ISBN 978-987-95081-0-7.\n[[43]](#_ftnref43)\nHans G. Schlegel, Medios de cultivos y condiciones de crecimiento, El crecimiento de los microorganismos\n, 1976, Ediciones Omega S.A. p. 193-196. ISBN 84-282-1030-6.\n[[49]](#_ftnref49)\nOp Cit Samanth Subramanian.\n[[50]](#_ftnref50)\nZhu, D., & Tuo, W. (2016). QS-21: A Potent Vaccine Adjuvant\n. Natural products chemistry & research, 3(4), e113. Disponible en:\n[https://doi.org/10.4172/2329-6836.1000e113](https://doi.org/10.4172/2329-6836.1000e113)\n(Consultado el 28 de septiembre de 2020) \u201cEl adyuvante insignia de Agenus es el QS-21, el cual se encuentra siendo utilizado por algunos desarrolladores de la vacuna de la Covid. El ingrediente activo de QS-21 proviene del \u00e1rbol de la corteza de un \u00e1rbol que crece en las monta\u00f1as de Chile; su corteza tiene que ser recolectada en el verano austral, convertida en pur\u00edn y procesada.\u201d\n[[51]](#_ftnref51)\nGSK, GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations\n. Disponible en:\n[https://www.gsk.com/en-gb/media/press-releases/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant/](https://www.gsk.com/en-gb/media/press-releases/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant/)\n(Consultado el 28 de septiembre de 2020) \u201cEn mayo, GlaxoSmithKline anunci\u00f3 fabricar\u00eda mil millones de unidades de su adyuvante AS03, que ha funcionado con las vacunas contra la gripe pand\u00e9mica, para suministrar a m\u00faltiples desarrolladores de vacunas Covid en todo el mundo. GlaxoSmithKline. GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations.\u201d\n[[57]](#_ftnref57)\nJoseph P. Lane, Understanding Technology Transfer\n. Assistive Technology, Junio de 1999. P. 5 \u2013 19, Pag 5.\n[[58]](#_ftnref58)\nMartin Friede, Laszlo Palkonyay, Claudia Alfonso, Yuri Pervikov, Guido Torelli, David Wood, Marie Paule, WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer\n,\n[Volumen 29, Supplement 1](https://www.sciencedirect.com/science/journal/0264410X/29/supp/S1)\n, 1 Julio de 2011, P\u00e1ginas A2-A7.\n[[60]](#_ftnref60)\nOp Cit, Martin Friede, pag A3\n[[71]](#_ftnref71)\nJos\u00e9 A. Vega and Pamella S. Ochoa, Supplies and Equipment for Compounding and Administering Sterile\n, Disponible en la web: Preparations samples.jbpub.com/9781284035728/9781449678630_CH02.pdf (Consultado el 28 de septiembre de 2020)\n[[75]](#_ftnref75)\nSubpartida arancelaria HS (2017) 350400.\n[[76]](#_ftnref76)\nSubpartida arancelaria HS (2017) 300290, 300120, 300190, 300212 y 300290.\n[[77]](#_ftnref77)\nSubpartida arancelaria HS (2017) 901890\n[[78]](#_ftnref78)\nSubpartida arancelaria HS (2017) 901832 y 901831\n[[79]](#_ftnref79)\nSubpartida arancelaria HS (2017) 481810\n[[80]](#_ftnref80)\nSubpartida arancelaria HS (2017) 841920", "language": null, "image": "https://acuerdosrevista.mincit.gov.co/CMSPages/GetFile.aspx?guid=b8b6bc1f-93d6-4e01-8e74-f568e3c175bb", "pagetype": "article", "links": ["#", "#", "#", "/", "", "/", "/editorial", "/articulos", "/conceptos", "/actualidad", "/ediciones", "#", "/", "/articulos", null, "#_ftn1", "#_ftn2", null, "#_ftn3", "#_ftn4", "#_ftn5", "#_ftn6", null, "#_ftn7", "#_ftn8", "#_ftn9", "#_ftn10", "#_ftn11", null, "#_ftn12", "#_ftn13", "#_ftn14", "#_ftn15", "#_ftn16", "#_ftn17", null, "#_ftn18", "#_ftn19", "#_ftn20", "#_ftn21", "#_ftn22", "#_ftn23", "#_ftn24", "#_ftn25", "#_ftn26", "#_ftn27", "#_ftn28", "#_ftn29", "#_ftn30", "#_ftn31", "#_ftn32", "#_ftn33", "#_ftn34", "#_ftn35", null, null, "#_ftn36", "#_ftn37", "#_ftn38", "#_ftn39", "#_ftn40", "#_ftn41", "#_ftn42", "#_ftn43", "#_ftn44", "#_ftn45", "#_ftn46", "#_ftn47", "#_ftn48", "#_ftn49", "#_ftn50", "#_ftn51", "#_ftn52", null, null, "#_ftn53", "#_ftn54", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "#_ftn55", "#_ftn56", null, "#_ftn57", "#_ftn58", "#_ftn59", "#_ftn60", "#_ftn61", null, "#_ftn62", "#_ftn63", "#_ftn64", "#_ftn65", "#_ftn66", null, "#_ftn67", null, null, null, "#_ftn68", null, null, "#_ftn69", "#_ftn70", "#_ftn71", "#_ftn72", "#_ftn73", "#_ftn74", "#_ftn75", "#_ftn76", "#_ftn77", "#_ftn78", "#_ftn79", "#_ftn80", null, null, null, "http://www.altenergystocks.com/archives/2020/08/amyris-sugarcane-derived-vaccine-adjuvant/", "https://www.who.int/immunization/quality_safety/en/", "https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKBN25Q0H9", "https://www.bbc.com/mundo/noticias-internacional-53254231", "https://www.bbc.com/mundo/noticias-54082322", "https://www.bloomberg.com/features/2020-covid-vaccine-manufacturing-essentials/", "http://www.cansinotech.com/upload/1/editor/1598075683375.pdf", "https://www.cdc.gov/vaccines/basics/test-approve.html", "https://cepi.net/COVAX/", "http://www.chictr.org.cn/showprojen.aspx?proj=56651", "https://www.conacyt.gov.py/facen-realizo-capacitacion-sobre-fundamentos-biorreactores-tecnologia-fermentacion", "https://www.merriam-webster.com/dictionary/vaccine", "https://www.wto.org/english/news_e/news20_e/rese_03apr20_e.pdf", "https://www.britannica.com/science/vaccine", "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2020-004123-16", "https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX", "https://www.france24.com/en/20200504-trump-promises-covid-19-vaccine-by-end-of-the-year", "https://www.elfinanciero.com.mx/bloomberg-businessweek/el-largo-y-costoso-camino-a-la-vacuna", "https://www.gsk.com/en-gb/media/press-releases/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant/", "https://www.gsk.com/en-gb/research-and-development/development/how-we-develop-new-vaccines/", "https://www.ifpma.org/wp-content/uploads/2016/01/IFPMA_Complex_Journey_Vaccine_Publication_2014_Spanish.pdf", "http://158.232.12.119/phi/news/Presentation11.pdf", "https://www.macmap.org/covid19", "https://www.jnj.com/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19-landmark-new-partnership-with-u-s-department-of-health-human-services-and-commitment-to-supply-one-billion-vaccines-worldwide-for-emergency-pandemic-use", "https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html", "https://theconversation.com/where-are-we-at-with-developing-a-vaccine-for-coronavirus-134784", "https://edition.cnn.com/2020/09/03/health/coronavirus-vaccine-october-unlikely/index.html", "https://www.sciencedirect.com/science/journal/0264410X/29/supp/S1", "https://media.nature.com/original/magazine-assets/d41586-020-02278-5/d41586-020-02278-5.pdf", "https://www.bbc.com/news/health-53741966", "https://www.wto.org/english/tratop_e/covid19_e/notifications_e.htm", "https://www.who.int/initiatives/act-accelerator/covax", "https://www.who.int/docs/default-source/biologicals/documents/relevant-who-documents-for-sars-cov-2-vaccines-and-other-biologicals-tz-ik-7-apr-2020.pdf?sfvrsn=c0531396_2", "https://apps.who.int/iris/bitstream/handle/10665/332070/9789240005105-eng.pdf", "https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines", "https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/", "https://www.wto.org/english/tratop_e/covid19_e/export_prohibitions_report_e.pdf", "https://www.reuters.com/article/us-health-coronavirus-sanofi/sanofi-france-chief-sees-coronavirus-vaccine-priced-below-10-euros-idUSKBN25W0EU", "https://www.elfinanciero.com.mx/bloomberg-businessweek/y-como-nos-vamos-a-poner-todos-la-vacuna-cuando-este-lista", "https://www.elfinanciero.com.mx/bloomberg-businessweek/y-como-nos-vamos-a-poner-todos-la-vacuna-cuando-este-lista", "https://clinicaltrials.gov/ct2/show/NCT04505722?term=NCT04505722&draw=2&rank=1", "https://clinicaltrials.gov/ct2/show/NCT04470427?term=vaccine&cond=covid-19&draw=5", "https://clinicaltrials.gov/ct2/show/NCT04530396?term=vaccine&cond=covid-19&draw=3", "https://clinicaltrials.gov/ct2/show/NCT04540419?term=vaccine&cond=covid-19&draw=6", "https://clinicaltrials.gov/ct2/show/NCT04368728?term=vaccine&cond=covid-19&draw=3", "https://www.mpg.de/14773435/corona-covid19-vaccine-production", "https://www.consumer.es/salud/investigacion-medica/como-hace-vacuna.html", "https://www.worldbank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii", "https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine", "https://bitesizebio.com/13682/passaging-suspension-cells-tutorial/", "https://doi.org/10.4172/2329-6836.1000e113", "#_ftnref1", "https://www.worldbank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii", "#_ftnref2", "https://media.nature.com/original/magazine-assets/d41586-020-02278-5/d41586-020-02278-5.pdf", "#_ftnref3", "https://www.bbc.com/news/health-53741966", "#_ftnref4", "#_ftnref5", "https://edition.cnn.com/2020/09/03/health/coronavirus-vaccine-october-unlikely/index.html", "#_ftnref6", "https://www.bbc.com/mundo/noticias-54082322", "#_ftnref7", "https://www.merriam-webster.com/dictionary/vaccine", "#_ftnref8", "https://www.britannica.com/science/vaccine", "#_ftnref9", "#_ftnref10", "#_ftnref11", "https://apps.who.int/iris/bitstream/handle/10665/332070/9789240005105-eng.pdf", "#_ftnref12", "https://www.france24.com/en/20200504-trump-promises-covid-19-vaccine-by-end-of-the-year", "#_ftnref13", "https://theconversation.com/where-are-we-at-with-developing-a-vaccine-for-coronavirus-134784", "#_ftnref14", "https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine", "#_ftnref15", "https://www.gsk.com/en-gb/research-and-development/development/how-we-develop-new-vaccines/", "#_ftnref16", "https://www.cdc.gov/vaccines/basics/test-approve.html", "#_ftnref17", "#_ftnref18", "https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines", "#_ftnref19", "https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html", "#_ftnref20", "#_ftnref21", "https://clinicaltrials.gov/ct2/show/NCT04540419?term=vaccine&cond=covid-19&draw=6", "#_ftnref22", "https://clinicaltrials.gov/ct2/show/NCT04530396?term=vaccine&cond=covid-19&draw=3", "#_ftnref23", "https://clinicaltrials.gov/ct2/show/NCT04505722?term=NCT04505722&draw=2&rank=1", "#_ftnref24", "https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX", "#_ftnref25", "http://www.chictr.org.cn/showprojen.aspx?proj=56651", "#_ftnref26", "https://clinicaltrials.gov/ct2/show/NCT04470427?term=vaccine&cond=covid-19&draw=5", "#_ftnref27", "https://clinicaltrials.gov/ct2/show/NCT04368728?term=vaccine&cond=covid-19&draw=3", "#_ftnref28", "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2020-004123-16", "#_ftnref29", "https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/", "#_ftnref30", "https://www.reuters.com/article/us-health-coronavirus-sanofi/sanofi-france-chief-sees-coronavirus-vaccine-priced-below-10-euros-idUSKBN25W0EU", "#_ftnref31", "https://www.jnj.com/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19-landmark-new-partnership-with-u-s-department-of-health-human-services-and-commitment-to-supply-one-billion-vaccines-worldwide-for-emergency-pandemic-use", "#_ftnref32", "http://www.cansinotech.com/upload/1/editor/1598075683375.pdf", "#_ftnref33", "https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKBN25Q0H9", "#_ftnref34", "#_ftnref35", "https://www.macmap.org/covid19", "#_ftnref36", "https://www.consumer.es/salud/investigacion-medica/como-hace-vacuna.html", "#_ftnref37", "#_ftnref38", "https://www.mpg.de/14773435/corona-covid19-vaccine-production", "#_ftnref39", "#_ftnref40", "#_ftnref41", "https://www.conacyt.gov.py/facen-realizo-capacitacion-sobre-fundamentos-biorreactores-tecnologia-fermentacion", "#_ftnref42", "#_ftnref43", "#_ftnref44", "https://bitesizebio.com/13682/passaging-suspension-cells-tutorial/", "#_ftnref45", "https://www.elfinanciero.com.mx/bloomberg-businessweek/el-largo-y-costoso-camino-a-la-vacuna", "#_ftnref46", "https://www.elfinanciero.com.mx/bloomberg-businessweek/y-como-nos-vamos-a-poner-todos-la-vacuna-cuando-este-lista", "#_ftnref47", "#_ftnref48", "https://www.ifpma.org/wp-content/uploads/2016/01/IFPMA_Complex_Journey_Vaccine_Publication_2014_Spanish.pdf", "#_ftnref49", "#_ftnref50", "https://doi.org/10.4172/2329-6836.1000e113", "#_ftnref51", "https://www.gsk.com/en-gb/media/press-releases/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant/", "#_ftnref52", "http://www.altenergystocks.com/archives/2020/08/amyris-sugarcane-derived-vaccine-adjuvant/", "#_ftnref53", "#_ftnref54", "#_ftnref55", "https://www.who.int/immunization/quality_safety/en/", "#_ftnref56", "https://www.who.int/docs/default-source/biologicals/documents/relevant-who-documents-for-sars-cov-2-vaccines-and-other-biologicals-tz-ik-7-apr-2020.pdf?sfvrsn=c0531396_2", "#_ftnref57", "#_ftnref58", "https://www.sciencedirect.com/science/journal/0264410X/29/supp/S1", "#_ftnref59", "#_ftnref60", "#_ftnref61", "http://158.232.12.119/phi/news/Presentation11.pdf", "#_ftnref62", "https://www.who.int/initiatives/act-accelerator/covax", "#_ftnref63", "#_ftnref64", "#_ftnref65", "#_ftnref66", "https://cepi.net/COVAX/", "#_ftnref67", "https://www.bbc.com/mundo/noticias-internacional-53254231", "#_ftnref68", "https://www.elfinanciero.com.mx/bloomberg-businessweek/y-como-nos-vamos-a-poner-todos-la-vacuna-cuando-este-lista", "#_ftnref69", "https://www.wto.org/english/tratop_e/covid19_e/export_prohibitions_report_e.pdf", "#_ftnref70", "https://www.bloomberg.com/features/2020-covid-vaccine-manufacturing-essentials/", "#_ftnref71", "#_ftnref72", "https://www.wto.org/english/tratop_e/covid19_e/notifications_e.htm", "#_ftnref73", "https://www.wto.org/english/news_e/news20_e/rese_03apr20_e.pdf", "#_ftnref74", "https://www.wto.org/english/tratop_e/covid19_e/export_prohibitions_report_e.pdf", "#_ftnref75", "#_ftnref76", "#_ftnref77", "#_ftnref78", "#_ftnref79", "#_ftnref80", "https://www.facebook.com/sharer.php?u=https://acuerdosrevista.mincit.gov.co/articulos/las-principales-barreras-comerciales-por-superar-p&t=Las principales barreras comerciales por superar para lograr un acceso global de la vacuna contra el COVID \u2013 19", "https://twitter.com/share?url=https://acuerdosrevista.mincit.gov.co/articulos/las-principales-barreras-comerciales-por-superar-p&text=Las principales barreras comerciales por superar para lograr un acceso global de la vacuna contra el COVID \u2013 19", "https://www.linkedin.com/shareArticle?mini=true&url=https://acuerdosrevista.mincit.gov.co/articulos/las-principales-barreras-comerciales-por-superar-p", "whatsapp://send?text=https://acuerdosrevista.mincit.gov.co/articulos/las-principales-barreras-comerciales-por-superar-p", "#", "/actualidad/casos-y-novedades-en-el-sistema-de-solucion-de-dif", "/actualidad/casos-y-novedades-en-el-sistema-de-solucion-de-dif", "/actualidad/diez-anos-del-tratado-de-libre-comercio-entre-colo", "/actualidad/diez-anos-del-tratado-de-libre-comercio-entre-colo", "/actualidad/restablecimiento-relaciones-colombia-venezuela", "/actualidad/restablecimiento-relaciones-colombia-venezuela", "#", "/ediciones/onceava-edicion/pdf/acuerdos9.aspx", "/ediciones/decima-edicion/pdf/acuerdos9.aspx", "/ediciones/novena-edicion/pdf/acuerdos9.aspx", "/ediciones/octava-edicion/pdf/octava-edicion.aspx", "/ediciones-anteriores/septima-edicion/pdf/acuerdos7.aspx", "/ediciones-anteriores/sexta-edicion/pdf/acuerdos6.aspx", "/ediciones-anteriores/quinta-edicion/pdf/acuerdos5.aspx", "/ediciones-anteriores/cuarta-edicion/pdf/acuerdos4.aspx", "/ediciones-anteriores/tercera-edicion/pdf/acuerdos3.aspx", "/ediciones-anteriores/segunda-edicion/pdf/acuerdos2.aspx", "/ediciones-anteriores/primera-edicion/pdf/acuerdos1.aspx", "#", "https://twitter.com/MincomercioCo?ref_src=twsrc%5Etfw", "http://mlr.vicepresidencia.gov.co/", "http://www.minjusticia.gov.co/", "https://www.mindefensa.gov.co/irj/portal/Mindefensa", "http://www.mininterior.gov.co/", "https://www.cancilleria.gov.co/", "http://www.minhacienda.gov.co/HomeMinhacienda/faces/wcnav_defaultSelection", "https://www.minminas.gov.co/", "http://www.mincit.gov.co/", "https://www.mintic.gov.co/portal/604/w3-channel.html", "http://www.mincultura.gov.co/Paginas/default.aspx", "https://www.minagricultura.gov.co/paginas/default.aspx", "http://www.minambiente.gov.co/", "https://www.mintransporte.gov.co/", "http://www.minvivienda.gov.co/", "https://www.mineducacion.gov.co/portadilla/index.html", "http://www.mintrabajo.gov.co/web/guest/inicio", "https://www.minsalud.gov.co/Paginas/default.aspx", "http://www.mincit.gov.co/servicio-al-ciudadano", "/", "http://www.mincit.gov.co/servicio-al-ciudadano/modulo-pqrsd", "http://www.mincit.gov.co/normatividad/notificaciones-administrativas-por-aviso", "http://www.mincit.gov.co/servicio-al-ciudadano/transparencia-y-acceso-a-la-informacion/ley-de-proteccion-de-datos-aviso-de-privacidad", "mailto:consultasoali@mincit.gov.co"]}